Literature DB >> 25631985

Familial schwannomatosis with a germline mutation of SMARCB1 in Japan.

Katsunori Asai1, Shoichi Tani, Yohei Mineharu, Yoshinori Tsurusaki, Yukihiro Imai, Yuji Agawa, Koichi Iwaki, Naomichi Matsumoto, Nobuyuki Sakai.   

Abstract

Schwannomatosis is the third major form of neurofibromatosis (NF) and is distinct from NF1 and NF2. The disease is not well recognized in Asian countries and the role of germline SMARCB1 mutations requires investigation. A 35-year-old Japanese man complaining of headache underwent an MRI examination, which showed a cystic tumor at the left cerebellopontine angle. The tumor was surgically removed and diagnosed as vagus nerve schwannoma. He had a past medical history of multiple schwannomas of the neck, groin and intercostal nerves, which were also treated surgically. He had a family history of multiple schwannomas for his father and sister. Systemic examinations of these family members ruled out a diagnosis of NF1 or NF2, and thus schwannomatosis was suspected. Genetic analysis revealed a germline mutation (c. *82C > T) of SMARCB1, and a somatic mutation of NF2 without loss of heterozygosity at the chromosome 22 locus. This is the first report of familial schwannomatosis associated with a germline mutation of SMARCB1 in an Asian country.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25631985     DOI: 10.1007/s10014-015-0213-9

Source DB:  PubMed          Journal:  Brain Tumor Pathol        ISSN: 1433-7398            Impact factor:   3.298


  6 in total

1.  Targeted next-generation sequencing for differential diagnosis of neurofibromatosis type 2, schwannomatosis, and meningiomatosis.

Authors:  Camille Louvrier; Eric Pasmant; Audrey Briand-Suleau; Joëlle Cohen; Patrick Nitschké; Juliette Nectoux; Lucie Orhant; Cécile Zordan; Cyril Goizet; Stéphane Goutagny; Dominique Lallemand; Michel Vidaud; Dominique Vidaud; Michel Kalamarides; Béatrice Parfait
Journal:  Neuro Oncol       Date:  2018-06-18       Impact factor: 12.300

2.  Clinical characteristics and genetic testing outcome of suspected hereditary peripheral nerve sheath tumours in a tertiary cancer institution in Singapore.

Authors:  Jerold Loh; Pei Yi Ong; Denise Li Meng Goh; Mark E Puhaindran; Balamurugan A Vellayappan; Samuel Guan Wei Ow; Gloria Chan; Soo-Chin Lee
Journal:  Hered Cancer Clin Pract       Date:  2022-06-13       Impact factor: 2.164

3.  Phenotypic and genotypic overlap between mosaic NF2 and schwannomatosis in patients with multiple non-intradermal schwannomas.

Authors:  Hildegard Kehrer-Sawatzki; Lan Kluwe; Reinhard E Friedrich; Anna Summerer; Eleonora Schäfer; Ute Wahlländer; Cordula Matthies; Isabel Gugel; Said Farschtschi; Christian Hagel; David N Cooper; Victor-Felix Mautner
Journal:  Hum Genet       Date:  2018-07-13       Impact factor: 4.132

Review 4.  The molecular pathogenesis of schwannomatosis, a paradigm for the co-involvement of multiple tumour suppressor genes in tumorigenesis.

Authors:  Hildegard Kehrer-Sawatzki; Said Farschtschi; Victor-Felix Mautner; David N Cooper
Journal:  Hum Genet       Date:  2016-12-05       Impact factor: 4.132

5.  Hereditary intraspinal schwannomatosis with SMARCB1 gene mutation: A case report.

Authors:  Yu Li; Lulu Chen; Dongqi Shao; Binbin Zhang; Shan Xie; Xialin Zheng; Zhiquan Jiang
Journal:  J Clin Lab Anal       Date:  2022-04-21       Impact factor: 3.124

6.  Multiparametric whole-body anatomic, functional, and metabolic imaging characteristics of peripheral lesions in patients with schwannomatosis.

Authors:  Shivani Ahlawat; Asad Baig; Jaishri O Blakeley; Michael A Jacobs; Laura M Fayad
Journal:  J Magn Reson Imaging       Date:  2016-03-17       Impact factor: 5.119

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.